<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04703010</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A02117-32</org_study_id>
    <nct_id>NCT04703010</nct_id>
  </id_info>
  <brief_title>Neonatal Precursors of Neurodevelopment</brief_title>
  <acronym>NEOPRENE</acronym>
  <official_title>Neonatal Precursors of Neurodevelopment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The NEOPRENE project proposes to examine processes that are among the earliest precursors of&#xD;
      cognitive functions and assess 1) the relationship between neonatal cognitive precursors and&#xD;
      cortical structure, structural connectivity and functional connectivity at birth and 2) the&#xD;
      relationship between neonatal cognitive precursors and neurodevelopment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Longitudinal study with measures at birth and at age 2.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Electroencephalography evoked response amplitude</measure>
    <time_frame>35 weeks of gestational age</time_frame>
    <description>Electrical field potential changes in the parietal and frontal cortices</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Near infrared spectroscopy evoked response amplitude</measure>
    <time_frame>35 weeks of gestational age</time_frame>
    <description>Oxygenated hemoglobin concentration changes in the somatosensory cortex</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Grey matter volume in the somatosensory cortex</measure>
    <time_frame>35 weeks GA</time_frame>
    <description>Thickness measured on T2 images in magnetic resonance imaging</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frontal-parietal structural connectivity</measure>
    <time_frame>35 weeks GA</time_frame>
    <description>Tractography using Diffusion tensor Imaging in magnetic resonance imaging</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frontal-parietal functional connectivity</measure>
    <time_frame>35 weeks GA</time_frame>
    <description>Synchronization at rest using blood-oxygen level dependent signal in magnetic resonance imaging</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of cognitive development</measure>
    <time_frame>2 years old</time_frame>
    <description>Qualitative composite assessment using clinical interview, routine pediatric screening and questionnaires (full sensory profile, preschooler Behavior Rating Inventory of Executive Function)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Premature Birth</condition>
  <arm_group>
    <arm_group_label>All participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants undergo the same measurements (longitudinal design)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electroencephalography-Near infrared spectroscopy</intervention_name>
    <description>Brain activity will be measured using 128-channel EEG and 2 channel NIRS during tactile stimulation (15 minutes sequence of vibrations) while the newborn is asleep.</description>
    <arm_group_label>All participants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic resonance imaging</intervention_name>
    <description>Structural (T1-T2), siffusion tensor imaging and blood-oxygen level dependant signal will be acquired in a subset of 40 subjects (20 minutes while asleep)</description>
    <arm_group_label>All participants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychometric testing</intervention_name>
    <description>Cognitive evaluation at age 2 (Parental questionnaires on sensory profiles, executive functions and neurodevelopmental disorders screening, child tests : movement assessment battery, Laby, Head-toes-shoulders-knees)</description>
    <arm_group_label>All participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Preterm newborn (born &lt; 34 weeks + 6days)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Brain injury&#xD;
&#xD;
          -  Respiratory assistance on measurement day&#xD;
&#xD;
          -  Infection on measurement day&#xD;
&#xD;
          -  Sedation on measurement day&#xD;
&#xD;
          -  Parents &lt; 18 years old or unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <link>
    <url>https://anr.fr/Projet-ANR-19-CE37-0015</url>
    <description>funding information</description>
  </link>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>January 4, 2021</study_first_submitted>
  <study_first_submitted_qc>January 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 11, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

